Is Heartbeam Stock a Good Investment?
Heartbeam Investment Advice | BEAT |
- Examine Heartbeam's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Heartbeam's leadership team and their track record. Good management can help Heartbeam navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Heartbeam's business and its evolving consumer preferences.
- Compare Heartbeam's performance and market position to its competitors. Analyze how Heartbeam is positioned in terms of product offerings, innovation, and market share.
- Check if Heartbeam pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Heartbeam's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Heartbeam stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Heartbeam is a good investment.
Sell | Buy |
Hold
Market Performance | OK | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Heartbeam Stock
Researching Heartbeam's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 29.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Heartbeam recorded a loss per share of 0.68. The entity had not issued any dividends in recent years.
To determine if Heartbeam is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Heartbeam's research are outlined below:
| Heartbeam appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (14.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heartbeam currently holds about 9.27 M in cash with (12.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16. | |
| Roughly 29.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Personal Care Stocks Q3 In Review BeautyHealth Vs Peers |
Heartbeam Quarterly Liabilities And Stockholders Equity |
|
Heartbeam uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Heartbeam. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Heartbeam's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Heartbeam's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Heartbeam's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2015-02-19 | 2014-12-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2014-08-01 | 2014-06-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2011-08-08 | 2011-06-30 | -0.06 | -0.05 | 0.01 | 16 | ||
2009-08-05 | 2009-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2009-04-30 | 2009-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2008-10-30 | 2008-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2008-07-22 | 2008-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2024-11-07 | 2024-09-30 | -0.17 | -0.19 | -0.02 | 11 |
Heartbeam Target Price Consensus
Heartbeam target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Heartbeam's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Buy |
Most Heartbeam analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Heartbeam stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Heartbeam, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationHeartbeam Target Price Projection
Heartbeam's current and average target prices are 3.06 and 5.39, respectively. The current price of Heartbeam is the price at which Heartbeam is currently trading. On the other hand, Heartbeam's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Heartbeam Target Price
Heartbeam Analyst Ratings
Heartbeam's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Heartbeam stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Heartbeam's financials, market performance, and future outlook by experienced professionals. Heartbeam's historical ratings below, therefore, can serve as a valuable tool for investors.Know Heartbeam's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Heartbeam is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Heartbeam backward and forwards among themselves. Heartbeam's institutional investor refers to the entity that pools money to purchase Heartbeam's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Pasadena Private Wealth, Llc | 2024-09-30 | 60.6 K | Blackrock Inc | 2024-06-30 | 51.4 K | Advisory Research Inc | 2024-09-30 | 50 K | Northern Trust Corp | 2024-09-30 | 46.8 K | D'orazio & Associates Inc | 2024-09-30 | 33 K | Xtx Topco Ltd | 2024-09-30 | 14.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 14.5 K | Harbour Investments, Inc. | 2024-09-30 | 14.2 K | Advisor Group Holdings, Inc. | 2024-06-30 | 11.6 K | Vanguard Group Inc | 2024-09-30 | 750.7 K | Smith, Salley & Associates, Llc | 2024-09-30 | 250 K |
Heartbeam's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.6 M.Market Cap |
|
Heartbeam's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.85) | (0.90) | |
| Return On Capital Employed | (0.96) | (0.91) | |
| Return On Assets | (0.85) | (0.90) | |
| Return On Equity | (0.92) | (0.87) |
Determining Heartbeam's profitability involves analyzing its financial statements and using various financial metrics to determine if Heartbeam is a good buy. For example, gross profit margin measures Heartbeam's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Heartbeam's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Heartbeam's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heartbeam. Check Heartbeam's Beneish M Score to see the likelihood of Heartbeam's management manipulating its earnings.
Evaluate Heartbeam's management efficiency
Heartbeam has return on total asset (ROA) of (0.6975) % which means that it has lost $0.6975 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1362) %, meaning that it created substantial loss on money invested by shareholders. Heartbeam's management efficiency ratios could be used to measure how well Heartbeam manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.9 in 2024. Return On Capital Employed is likely to gain to -0.91 in 2024. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 16.3 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.78 | 0.74 | |
| Tangible Book Value Per Share | 0.78 | 0.82 | |
| Enterprise Value Over EBITDA | 46.81 | 49.15 | |
| Price Book Value Ratio | 3.00 | 3.15 | |
| Enterprise Value Multiple | 46.81 | 49.15 | |
| Price Fair Value | 3.00 | 3.15 | |
| Enterprise Value | 32.6 M | 45.9 M |
Evaluating the management effectiveness of Heartbeam allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Heartbeam Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta (0.99) |
Basic technical analysis of Heartbeam Stock
As of the 1st of December, Heartbeam retains the market risk adjusted performance of 0.5241, and Risk Adjusted Performance of 0.1066. Heartbeam technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Heartbeam's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heartbeam insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heartbeam's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heartbeam insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Heartbeam's Outstanding Corporate Bonds
Heartbeam issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Heartbeam uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Heartbeam bonds can be classified according to their maturity, which is the date when Heartbeam has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Heartbeam's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Heartbeam's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1066 | |||
| Market Risk Adjusted Performance | 0.5241 | |||
| Mean Deviation | 3.36 | |||
| Semi Deviation | 3.11 | |||
| Downside Deviation | 3.69 | |||
| Coefficient Of Variation | 778.04 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.67 | |||
| Information Ratio | 0.099 | |||
| Jensen Alpha | 0.4422 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.1249 | |||
| Treynor Ratio | 0.5141 | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (6.23) | |||
| Potential Upside | 10.3 | |||
| Downside Variance | 13.6 | |||
| Semi Variance | 9.7 | |||
| Expected Short fall | (4.14) | |||
| Skewness | 0.773 | |||
| Kurtosis | 1.17 |
| Risk Adjusted Performance | 0.1066 | |||
| Market Risk Adjusted Performance | 0.5241 | |||
| Mean Deviation | 3.36 | |||
| Semi Deviation | 3.11 | |||
| Downside Deviation | 3.69 | |||
| Coefficient Of Variation | 778.04 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.67 | |||
| Information Ratio | 0.099 | |||
| Jensen Alpha | 0.4422 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.1249 | |||
| Treynor Ratio | 0.5141 | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (6.23) | |||
| Potential Upside | 10.3 | |||
| Downside Variance | 13.6 | |||
| Semi Variance | 9.7 | |||
| Expected Short fall | (4.14) | |||
| Skewness | 0.773 | |||
| Kurtosis | 1.17 |
Consider Heartbeam's intraday indicators
Heartbeam intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heartbeam stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Heartbeam Corporate Filings
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 23rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 20th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 11th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Heartbeam Stock media impact
Far too much social signal, news, headlines, and media speculation about Heartbeam that are available to investors today. That information is available publicly through Heartbeam media outlets and privately through word of mouth or via Heartbeam internal channels. However, regardless of the origin, that massive amount of Heartbeam data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Heartbeam news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heartbeam relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heartbeam's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heartbeam alpha.
Heartbeam Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Heartbeam can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Heartbeam Corporate Management
| Branislav Vajdic | President, Founder | Profile | |
| FACC MD | Chief Officer | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Richard Brounstein | CFO Treasurer | Profile | |
| Richa Gujarati | Senior Product | Profile | |
| Kenneth Persen | Chief Officer | Profile |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.